14 /100
LOW RISK
Score updated Jul 13, 2026

NHI — National Health Investors, Inc. Dilution Risk Tracker

Track NHI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NHI — Get alerts when the score changes →

As of July 13, 2026, National Health Investors, Inc. (NHI) has a DilutionWatch DilutionScore of 14/100, rated LOW dilution risk. National Health Investors, Inc. has a market capitalization of $3.55B, 48.47M shares outstanding, 320 institutional holders tracked. Key dilution vectors include ATM program capacity of $500.00M, approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
30
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
9%
💰 Capital Raise 18%
• Active ATM program with $500M remaining capacity
🔔 Track NHI — Get forecast alerts →

💹 Market Data

Market Cap$3.55B
Shares Outstanding48.47M
Float46.34M
Cash$24.95M
Debt$1.13B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 10.4% shares (2026Q1 vs prior)
320 institutional holders · 39.11M shares
#1 BlackRock, Inc. 4.81M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.17M shares
#3 VANGUARD PORTFOLIO MANAGEMENT LLC 4.14M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.74M
Days to Cover2.4
% of Float8.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2020
8-K 8K EVENT Mar 16, 2026
424B5 ATM Mar 16, 2026
4 INSIDER TRANSACTION Mar 05, 2026
4 INSIDER TRANSACTION Mar 05, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NHI Shareholders

National Health Investors, Inc. (NHI) has a DilutionScore of 14/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

NHI has an active ATM (at-the-market) program with $500.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event.

DilutionWatch tracks over 25 SEC filing types for NHI in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for NHI alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work →
Track NHI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NHI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NHI
📊 NHI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NHI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.